Science Park nurtures record 108 incubatees, 41 patents registered

Thursday, May 28, 2020

A record 108 start-ups completed their incubation programmes and the Science and Technology Entrepreneur Programme (Step) today, the Hong Kong Science and Technology Parks Corporation, announced.

Their graduation was hosted virtually for the first time.

The graduates included 78 from HKSTP’s incubation programmes, Incu-Tech, Incu-App and Incu-Bio,and 30 from the new pre-incubation Step.

The 78 incubation graduates come from Hong Kong, China, India, Taiwan, UK and US. Collectively, this year’s graduates have applied or registered for 41 patents which is the highest in the past three years, while also receiving 56 international and local invention awards.

This year also marks a breakthrough moment for the Incu-Bio program with a record high of six graduates. The growth in this sector reinforces the thriving biotech ecosystem being cultivated at Hong Kong Science Park and proves Hong Kong’s emergence as a regional hub for biomedical technology, the park says.

Joining the current 140 plus biotech partner companies at Science Park, this year’s Incu-Bio graduates will continue their R&D..

Designed to identify and nurture future technopreneurs, the Step program established a year ago, has produced its first batch of the graduates this year. Several participants have confirmed their admission to HKSTP’s incubation program and they will receive further support and assistance from HKSTP.

Albert Wong, Chief Executive of HKSTP, said, the park always been an ideal breeding ground for global innovators, entrepreneurs, as well as research and development talent.

“As a key enabler of the city’s I&T ecosystem, HKSTP will continue to nurture talent and leverage our expansive network to broaden their business perspectives globally. ''

Photo 3: From left, George Tee, Chief Technology Officer, HKSTP, Jojo Cheung, Chief Marketing Officer,  Albert Wong, Chief Executive Officer, Dr Sunny Chai, BBS, Chairman, Kiki Wang, Director of Incubation and Acceleration Programs, Prof W. John Kao, Head of the Biomedical Technology Cluster, and Peter Mok, Head of Strategic Partnership.